19 October 2026 | Workshop Day
20-22 October 2026 | Conference & Exhibition
RAI Congress Centre, Amsterdam

R&D + Strategic Partnering For The
Global Vaccine Industry

apply to sponsor / exhibit / speak

REGISTER NOW

WHY ATTEND?

Europe's Largest Vaccine Event

From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.

2,500+

Attendees

280

Speakers

150+

Exhibitors

4

Days

2,000+

1 to 1 Partnering Meetings

18,000+

Networking Connections

Conference

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more

APPLY TO SPEAK

Exhibition

150+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions

APPLY TO SPONSOR/EXHIBIT

Networking

Networking is at the heart of World Vaccine Congress Europe. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking

The Start-to-Finish of Vaccines

From immune profiling & clinical development, to global health, supply, and access

Supply & Logistics
Learn how we are dealing with the supply demands and the technologies that will allow last mile delivery

New Technology
Innovations reshaping vaccine development and delivery

Cancer & Immunotherapy
Pioneering cancer vaccines and the future of immunotherapy combinations

Partnerships & Access
Secure funding, foster partnerships, and drive global market access

Covid & Beyond
Pandemic preparedness, next generation vaccines, broadly protective and combination approaches

Influenza & Respiratory
Cutting-edge developments in vaccines for respiratory diseases across all populations

Veterinary
Advancing veterinary vaccines and integrating the One Health approach to safeguard animal and public health

Global Health & Neglected Diseases
Advancing solutions for global health challenges and underserved diseases

Immune Profiling
Harness immune insights to design next-gen vaccines

Clinical Trials
Understand how to move your vaccine candidates through development phases to licensure

Working Groups
Interactive, discussion-driven sessions fostering collaboration and brainstorming among industry experts and participants

Emerging & Re-Emerging Diseases
Exploring innovative strategies and breakthroughs to combat emerging diseases and outbreak pathogens

Pre-Clinical Development
Optimising early-stage vaccine research and animal models

AMR & Bacterial Vaccines
Combating antimicrobial resistance through innovative bacterial vaccine solutions

Bioprocessing & Manufacturing
Meet with the manufacturers & bioprocessing experts to advance your vaccine formulation, tech transfer & scale-up

BioPharma Showcases
Explore the progress and innovations of biopharma companies advancing the next generation of vaccines and therapeutics

Provisional Agenda Overview

Apply To Speak

Past Speakers

Peter Aaby
Professor & Founder
Bandim Health Project

RAJESHWARI ADHISESHAN
senior program officer
Bill and Melinda Gates Foundation
Jeffrey Almond
Former VP Discovery R&D, Sanofi & Visiting Professor
University of Oxford

Irnela Bajrovic
VP of Alliances
Jurata
Christine Stabell Benn
Professor
University of Southern Denmark

Moy Bracken
Research Manager
Access to Medicine Foundation
Nicolas Burdin
Global Head of R&D
Clover Pharma

David Burkhart
CEO
Inimmune Corp
Michael Caldwell
Assoc VP Vaccine Research
Meharry Medical College

Andrew Catchpole
CSO
hVIVO
Johannes Charlier
CEO
Kreavet

Dennis Christensen
Head of Global R&D
Croda Pharma
Timothy Connelley
International Veterinary Vaccinology Network
University of Edinburgh

Dimitri Diavatopoulos
Associate Professor
Radboud Center for Infectious Diseases
Andrej Egorov
CSO
Nucell GmbH

Mark Emalfarb
Chief Executive Officer
Dyadic International Inc
Mathieu Epardaud
Co-founder
Lovaltech

Gonçalo Farias
Laboratory Manager, Nasal and Innovation Services
Aptar Pharma
Martin Peter Grobusch
Professor of Infectious Diseases & Global Health
Amsterdam UMC

Carlos Alberto Guzman
Head Of The Department Of Vaccinology And Applied Microbiology
Helmholtz Centre for Infection Research
Bart Haagmans
Virologist
Erasmus Medical Center

Matthew Higgins
E. P. Abraham Chair of Structural Biology
University of Oxford
Jayasree Iyer
Chief Executive Officer
Access to Medicine Foundation

Mark Jit
Chair and Professor, Department of Global and Environmental Health
NEW YORK UNIVERSITY
Alasdair King
Executive Director
Merck Animal Health

Zoltán Kis
Senior Lecturer (Associate Professor)
Department of Chemical and Biological Engineering, The University of Sheffield
Jelle Klein
CPU Medical Director
SGS Belgium NV.

Marguerite Koutsoukos
Sr Clinical Science Lead
GSK
Jose Maria Lagaron
Founder, CEO & CSO
BIONANOPHARMA

Alexandre Le Vert
CEO
Osivax
Darren Leneghan
Consultant, Life Sciences
Venture Valuation

Geert Leroux Roels
Professor Emeritus
Gent University
Kirsten Maertens
Assistant Professor, Vaccines & Infectious Disease Institute
University of Antwerp

Leonardo Magneschi
Vice President – Research & Technology Development
Ingenza Ltd
Alessandro Manenti
Chief Development Officer
Vismederi

Francisco Mazzei
Project Oversight Director, Vaccines
PPD, the Clinical Research business of Thermo Fisher Scientific
Ab Osterhaus
Director of Research Center For Emerging Infections and Zoonoses and Professor
University of Veterinary Medicine Hannover

Jan Poolman
Executive Advisor & Founder
CreaBacVac B.V.
Maarten Postma
Chair, Faculty of Economics & Business,
University of Groningen

Milla RUNSALA
Business Development Manager
DelSiTech Ltd
Björn Sjöstrand
Chief Executive Officer
Scandinavian Biopharma Holding AB

Jeffrey Stolwijk
Scientific Director
Uneedle
Jack Tan
Principal Investigator
University of Oxford

Sean Tucker
CSO
Vaxart
Sebastian Ulbert
Deputy Director
Fraunhofer-Institute for Cell Therapy and Immunology

Britt van de Ven
Program Manager Personalised Health
hollandbio
Nathaniel Whitley
Vaccination Committee
World Small Animal Veterinary Association

Y. Tony Yang
Professor
The George Washington University
Aleksandar Antanasijevic
Tenure Track Assistant Professor, Global Health Institute
École Polytechnique Fédérale de Lausanne (EPFL)

Jane Barratt
Global Advisor and Health Systems Strategist
International Federation On Ageing
Daniel Becker
Head of Business Development INACTIVATE
KyooBe Tech GmbH

Cedric Bogaert
Chief Executive Officer
myNEO Therapeutics
Maria Elena Bottazzi
Co-Director of Texas Children's Hospital Center for Vaccine Development
Baylor College of Medicine

Ed Buurman
Director Alliances
CARB-X
Marco Cavaleri
Head of Public Health Threats
European Medicines Agency

Tim Cooke
CEO
Omniose
Benjamin DAMIEN
CEO
Sagitta Biotech

Kashmira Date
Senior Director, Global Medical Affairs - RSV Adult and Pipeline Vaccines
Pfizer
Ingrid de Visser-Kamerling
Research Director
Stichting Centre for Human Drug Research

Kyle Doolan
Senior Director of Research & Development
Integral Molecular
Helge Dorfmueller
Professor of Glycoengineering / Founder RHAPSEDA
University of Dundee

Carel du Marchie Sarvaas
yes
HealthforAnimals
david farcas
Director, Chile
Yelcho

Thom Frielink
Sr. Associate
Curie Capital BV
Christina Go
Application Scientist
Integral Molecular

Bassam Hallis
Deputy Director, Vaccine Development & Evaluation Centre
UK Health Security Agency
Jonathan Hare
Translational Science Lead
The Francis Crick Institute

Mark Howarth
Sheild Chair of Pharmacology
University Of Cambridge
Ofer Levy
Director, Precision Vaccines Program
Boston Children's Hospital

Stephen Lockhart
Director
Hurst Grange Associates
Mats Lundgren
CSO
Abera Bioscience AB

Gerben Marsman
Head of Alliance Management
Vaccine Formulation Institute
Kayvon Modjarrad
Executive Director, Viral Vaccines
Pfizer

Elise Pepermans
CEO & Co-Founder
ImmuneSpec BV
Wolfgang Philipp
Principal Adviser, Chief Science Officer
European Commission Health Emergency Preparedness & Response (HERA)

Giovanna Riggall
Head of Heath Supply Chain
Unimed
Ruben Rizzi
SVP Global Regulatory Affairs
BioNTech SE

Meta Roestenberg
Clinical Head, Controlled Human Infection Center
Leiden University Medical Center (Netherlands)
Simona Rondini
Head Bacterial Vaccines and Senior Project Leader at GVGH
GSK Vaccines

Jerald Sadoff
Chief Medical Officer
Centivax
Jeremy Salt
Chief Executive Officer
The Vaccine Group

Tyler Sandberg
Product Manager
Mabtech
Miriam Taegtmeyer
Professor of Global Health
London School of Hygiene and tropical Medicine

Robbert Van der Most
CEO
Vaxxcellence
Bruno Vandelanotte
Sales Manager EMEA
Roncadelle-Operations

Joris Vandeputte
Past President
IABS
Vanessa Vankerckhoven
CEO & Founder
IDEVAX

Vijay Vaswani
Cofounder & CEO
Omniscope
Roland Ventura
VFI Advisor
Vaccine Formulation Institute

Cristina Alaimo
Head of Clinical, Senior Director Clinical and Regulatory
Limmatech
Fabrizio Chiodo
Associate Professor
Italian National Research Council

Jenny Hendriks
Global Lead Clinical Immunology
CEPI
Rico Hinrichs
Expert Development Mol. Biol.
IDT Biologika

Michael Sumner
Chief Medical Officer
Inovio Pharmaceuticals
Jenni Vuola
Business Development Advisor
Rokote Laboratories Finland Oy

Babita Agrawal
Professor
University of Alberta
Mario Barro
Head of Infectious Diseases at RA Capital. CEO/President at GIVAX
RA Capital

Ashley Brate
Associate Director
SeromYx
Robb Butler
Director, Division of Communicable Diseases Environment and Health
World health organisation

Lucy Chappell
Chief Scientific Adviser
UK Department of Health and Social Care
Kundai Chinyenze
Strategic Partnerships and Regional Director
IAVI

Mary De Silva
Deputy Chief Scientific Adviser
Department of Health and Social Care
Michel De Wilde
Former Senior Vice President R&D Of Sanofi Pasteur & Owner
MDW Consultant LLC

Andrew Deavin
Senior Director
GSK
Ruxandra Draghia-Akli
Executive Vice President, Head of Research and Development
Novavax

Rosybel Drury
Senior Director
MSD
Jonathan Fauerbach
Head of R&D
LenioBio

Pete Gardner
Scientific Director
LifeArc
Mark Geels
Senior Director
IAVI

Rosa Gini
Vice President and Head of the Pharmacoepidemiology Unit
VAC4EU
Seth Ginsberg
Co-Founder and President
Global Healthy Living Foundation

Swati Gupta
VP, Head of Emerging Infectious Diseases and Epidemiology
International AIDS Vaccine Initiative
Jonathan Heeney
Chief Scientific Officer
DIOSynVax Limited

Catherine Hoath
Global Regulatory Affairs Strategy Lead
CEPI
Kevin Kee-Jong Hong
Professor
Gachon University

Jerome Kim
Director General
ivi
Hester Kuipers
Executive Director Europe
IAVI

Marcus Lacey
Exec Director Global Pandemic
CSL Seqirus
Gemma Lahuerta Buira
Parenteral Development Director
LABORATORIO REIG JOFRE, S.A.

Thomas Lake
Chief Business Officer
Vaxxas Pty Ltd
Maja Leskovec
Head of PD viruses
Sartorius BIA Separations

Kutub Mahmood
Scientific Director
PATH
Chelsea McLean
Clinical Science Director
Johnson & Johnson

Ankur Mutreja
Director of External Affairs and Health Security
South Asia-PATH
Hanna Nohynek
Chief Physician
National Institute for Health and Welfare

Sibilia Quilici
Executive Director
Vaccines Europe
Nikki Romanik
Distinguished Senior Fellow
Brown University School of Public Health

Debabrata Roy
VAC4EU Executive Board Member
Drug Safety Research Unit
Morten Ruhwald
Chief Medical Officer
Novo Nordisk Foundation Initiative for Vaccines and Immunity

Hanneke Schuitemaker
CSO
Valneva Austria GMBH
Walter Straus
Vice President, Clinical Safety & Risk Management
Moderna Therapeutics

Miriam Sturkenboom
Professor in RWE & Head, Department of DataScience and Biostatistics, University Medical Center Utrecht & President
VAC4EU
Rajinder Suri
Chief Executive Officer
Developing Countries Vaccine Manufacturers Network

Hamid Trimech
Business Development
ARCALIS, Inc.
Nico Vandaele
Prof. dr.
KU Leuven, Access-To-Medicines Research Centre

Duco Veen
Manager
Julius Clinical
Charlie Weller
Head of Vaccines
Wellcome Trust

Sandeep Patel
CEO
Humanity Health Ventures
Kevin Kee-Jong Hong
Professor
K-Health MIRAE

Charlotte Vernhes
Director Scientific and Medical Affairs
Vaccines Europe
Erwin Blomsma
Chief Executive Officer
ViroVet

Martinus Capelle
Distinguished Scientist II
Janssen
Christine Dahlke
Translational Immunology Lead
CEPI

George Dakwar
Director Formulation Platform
CureVac AG
Valentino D'Onofrio
Postdoctoral Researcher
University of Ghent

Tom Garnett
CEO & Co-founder
Refute
Angela Luttick
EVP Commercial
360biolabs

Giovanni Mariggi
Partner
Medicxi
Narcisa Mesaros
MD, Vice President, Medical Science & Strategy, Vaccines & Infectious Disease
PPD, the Clinical Research business of Thermo Fisher Scientific

Shannon Miller
VP Operations
Inimmune Corporation
James P. McCormick
Senior Director, Regulatory Affairs
PPD, the Clinical Research business of Thermo Fisher Scientific

Heenal Patel
Head of Strategic Partnerships
Paratus Clinical
Sankarasubramanian Rajaram
Head of Global Medical Strategy
Seqirus

Xiaozhi Ren
Director
WuXi Vaccines
Nina van Sorge
Head of Netherlands Reference Laboratory for Bacterial Meningitis
AMC

Louis Ates
Senior Scientist - Infectious Disease Vaccines
BioNTech
Ivo Claassen
Head of Veterinary Medicines Division
EMA

Jakob Cramer
Head Of Clinical Development
CEPI
Dirk Hahneiser
CCO
Cocoon Bioscience

Damian Hiley
Managing Director, Vaccine Division
Desert King
Janet K Yamamoto
Professor of Immunology and Director of LCIV-CA
University of Florida

Emilie Karafillakis
European Director, Vaccine Confidence Project
London School of Hygiene and tropical Medicine
Merel Langelaar
Director
Biomedical primate research centre

Shelly Malhotra
Vice President Global Access & External Affairs
IAVI
Karen O'Hanlon
Chief Development Officer
Stablepharma

Zeil Rosenberg
Executive Vice President, Medical
Tonix Pharmaceuticals
Merijn Salverda
Scientist bacterial vaccines
Intravacc

Mads Skovvang
Manager, Commercial Supply Chain - EMEA
World Courier
Luigi Bonfatti
Executive Advisor
RVMC (Regionalized Vaccine Manufacturing Collaborative)

Edward Grahame
Alliance Manager - Nanomedicine Services
Cytiva
Roland Zahn
Senior Scientific Director, Head Nonclinical and Translational Immunology & Biomarkers, CDTL Universal Influenza Vaccine & CDTL
Johnson & Johnson

Fadil Bidmos
Associate Professor in Bacterial Vaccinology
Imperial College London
Dakshina Reddy
Head of Global Regulatory Strategy and Operations
Bill & Melinda Gates Medical Research Institute

Manki Song
Deputy Director General of Science
International Vaccine Institute
Ola Tuvesson
CTO
NorthX Biologics

Yvanne Enever
CEO
PHARMExcel
Igor Smolenov
Chief Development Officer
Arcturus Therapeutics

Jacob Cain
VP
Jurata
Pietro Mastroeni
Professor of Infection and Immunity
University of Cambridge

Mark Newman
Chief Scientific Officer
GeoVax
Kimberley Ramsey
BD Manager
PathoQuest

Mario Rodriguez
Sr Director MCM
Emergent Biosolutions
Lotte Steuten
Deputy CEO
Office of Health Economics

Erta Kalanxhi
Director of Partnerships
One Health Trust
Damian Alvarez-Paggi
CEO
Eureka Nanobioengineering

Pär Comstedt
VP Infectious Disease Vaccine Development
Evaxion Biotech A/S
Gerard Cunningham
OPERATING PARTNER
ADJUVANT CAPITAL

Marien de Jonge
Head of the Laboratory of Medical Immunology
Radboud University
Wian de Jongh
CEO
adaptvac

Samantha Dowse
Managing Partner/ CMC Consultant
GreyRigge Associates Limited
Je-Wook Lee
Project Manager
KHIDI Korea Health Industry Development Institute

Markus Mandler
CEO
Tridem Bioscience
Matthias Müllner
CEO
bespark*bio

Matilu Mwau
Senior Principal Clinical Research Scientist, Professor of Infectious Diseases
Kenya Medical Research Institute(KEMRI)
Umberto Perron, PhD
Senior Computational Biology
Omniscope

Melanie Saville
Chief Scientific Officer
PATH
Thomas Trolle
Director, Bioinformatics & AI/ML
Evaxion Biotech

Kabeer Aziz
Partner
ADJUVANT CAPITAL
Ilse De Coster
Head Ambulatory Clinical Trial Unit
University of Antwerp

Nicola Lewis
Director of Worldwide Influenza Centre
The Francis Crick Institute
George Simeon
CEO
Curevo Vaccine

Chirstopher Green
Professor and Consultant Physician in Infectious Diseases & Global Health
University of Birmingham
Hamilton Bennett
Executive Director, Health Security R&D and Partnerships
Moderna

Martine Boyer
Director Protein Science
IQVIA Laboratories
Jean-Pierre Amorij
Vaccine Technology Specialist
UNICEF

Stefania Di Marco
QP & Director of Quality Control
Advaxia Biologics
Yap Boum II
Deputy Head of the Mpox Response
Africa CDC

Christian Brander
Advisor
Omniscope
Ysaline Roland
Head of Bioprocess Department
NAOBIOS

Marco Soriani
Project Director
REITHERA SRL
Caitlin Asjes
Senior Director, Global Public Health
BD

Ali Azizi
Technical Lead
CEPI
Sanjib Banerjee
Chief Operations Officer
Veeda Lifesciences

Christophe BONNEVILLE
CEO
Dillico
Gabrielle Breugelmans
Director of Epidemiology and Data Science
CEPI

Fazlul-Hoque Chowdhury
Director
C-Mark Bio
James Clair
Bioprocess Engineer II
APC

Scott Cribbes
Market Development Leader
Revvity
Laurence de Moerlooze
Chief Medical Officer
P95

Alexander Douglas
Associate Professor
University of Oxford
Nicola Esposito
QC & Solutions Development Manager
Advaxia Biologics

Viviane Ferraz
Associate Director Patient Safety Scientist
Astra Zeneca
Jamie Findlow
Senior Director, Global Medical Strategy Lead, Meningococcal Vaccines
Pfizer

Daniel Fullen
Research and Development Innovations Lead
CEPI
Gregory Glenn
Chief Executive Officer
Pinion Immunotherapeutics

Lisa Herron-Olson
Managing Director
Syntiron
Shirley Hopper
Medical Assessor
MHRA

Jonathan Jones
Manager - Microbial Fermentation
CPI
Juhienah Khalaf
Director of Chemistry
Inimmune Corporation

Musaddiq Khan
VP, Customer Value - Digital Outcomes & TA Strategy
Medable
Prabuddha Kumar Kundu
Co-founder and MD
Premas Biotech

Niall Macaulay
Policy Officer
Health Emergency Preparedness and Response Authority
David Miller
VP of Strategic Communications
Curevo Vaccine

Luz Elena Moreno
Vaccines Medical Director
VaxTRIALS Part of Emmes Group
Larissa Osterbaan
Research Associate I
Integral Molecular

Arto Palmu
Chief Research and Medical Officer
FVR – Finnish Vaccine Research | FVR – Suomen rokotetutkimus
Katrien Poelaert
Senior Scientist
Ziphius NV

Reda Sadki
Executive Director
The Geneva Learning Foundation
Darin Seehafer
Executive Director Vaccine Business Development
VaxTRIALS Part of Emmes Group

Florence Vanthillo
Account Manager
Revvity
Eric Weaver
Director
Nebraska Center for Virology

Elissa R Weitzman
Associate Professor, Director of Research
Boston Children's Hospital, and Harvard Medical School
Richard White
Professor of Infectious Disease Epidemiology
London School of Hygiene and tropical Medicine

Julia Djonova
Head of ATMP division
Swissmedic
Joe Fitchett
Senior Advisor
Institut Pasteur

Ana Maria Henao-Restrepo
Lead R&D Blueprint for Epidemics, Health Emergencies Programme (WHE),
World health organisation
Gaurav Kanojia
Senior Business Development Manager
CEPI

Mihai Netea
Doctor
Radboud University Nijmegen Medical Centre
Rod O'Keeffe
Senior CMC Associate
GreyRigge Associates Limited

Tim Peterson
Scientific Director, Dermal Drug Delivery
Kindeva Drug Delivery
Paul Rolan
Chief Medical Officer
GPN Vaccines Ltd

Jeroen Stoop
Clinical Science Director
Johnson & Johnson
Federica Cappuccini
Senior Scientist
CEPI

Anna Takanen
Field Application Specialist
Novo Nordisk Pharmatech
Younbeen Kim
Project Manager
Health Security, K-Health MIRAE Initiative

Ilke De Boeck
postdoc researcher
Universiteit Antwerp
Elly van Riet
Senior Scientist
T.B.V.I.

Andrew Bate
VP & Head, Safety Innovation & Analytics, Global Safety
GSK
Sabrina Cardillo
R&D Scientific Manager
Biogenesis Bago S.A.

Markus Depfenhart
Professor/ PI SAVAC Project
North-West University
SUZANNA Francis
Senior Director & Head of Epidemiology
IAVI

Irina Meln
Head of Innovation
European Vaccine Initiative
Lee Sherlock
Co-Founder & CEO
Meta-Flux

Joanna Rejman
Head of Formulation
Novo Nordisk Foundation Initiative for Vaccines and Immunity
Rino Rappuoli
Scientific Director
Fondazione Biotecnopolo di Siena

Bryan Dalphy
Deputy Director
Health Emergency Readiness Canada-Government of Canada
Rob Dekker
CMC Leader
J&J

Saul Faust
Prof of Paediatric Immunology and Infectious Diseases
University of Southampton
Luc Gagnon
Global Head Vaccine Sciences
IQVIA Laboratories

Sarvesh Mutha
Chief Business Officer
INTEGRIMEDICAL PVT LTD.
Marielle van Hulten
Sr Principle Scientist, Regulatory Affairs Oncology, MSD
MSD

Denis Cavert
Chief Executive Officer
Vaxxel
Jan ter Meulen
Chair of Research
Virometix AG

Dominique Milea
RWE head Global Health
GSK
Jennifer Moisi
VP, Global Medical Franchise Lead, Bacterial and Vector Borne Vaccines
Pfizer

Manuela Mura
scientific officer
European Medicines Agency
Zoltan Beck
Science advisor
Desert King

Jerome Kim
Director General
International Vaccine Institute

APPLY TO SPEAK

VIEW PROSPECTUS

APPLY TO SPONSOR / EXHIBIT

World Vaccine Congress Europe 2023 Testimonials

“Thank you very much to you and the rest of the Terrapinn team for organising the conference and making it a face to face meeting - which we find so vital.”

- CSO, hVIVO

“I had the pleasure of meeting and interacting with scientists, colleagues, collaborators and friends while enjoying talks and discussions on vaccines, infectious diseases and pandemic preparedness for the future. ”

- Head of Laboratory Science, CEPI

“ Thank you so much for all the work put in the World Vaccine Congress Europe, it was an excellent event. ”

- Process Development Engineer & Digitalization Business Lead, APC Ltd.

Join the global vaccine community in Amsterdam
19-22 October, Amsterdam

Get your ticket now

R&D + Strategic Partnering For The
Global Vaccine Industry

Europe's Largest Vaccine Event

2,500+

280

150+

4

2,000+

18,000+

The Start-to-Finish of Vaccines

From immune profiling & clinical development, to global health, supply, and access

Past Speakers

Past Sponsors and Exhibitors

Join the global vaccine community in Amsterdam
19-22 October, Amsterdam

Get involved at World Vaccine Congress Europe 2026

TO SPONSOR

Christian Larsmon
Christian.Larsmon@terrapinn.com

Otto Squire
Otto.Squire@terrapinn.com

TO SPEAK

Isla Sutherland
Isla.Sutherland@terrapinn.com

MARKETING & PRESS

Jasper Cameron
Jasper.Cameron@terrapinn.com

Stay Up-to-Date

Created by

R&D + Strategic Partnering For The Global Vaccine Industry

Europe's Largest Vaccine Event

2,500+

280

150+

4

2,000+

18,000+

The Start-to-Finish of Vaccines

From immune profiling & clinical development, to global health, supply, and access

Past Speakers

Past Sponsors and Exhibitors

Join the global vaccine community in Amsterdam 19-22 October, Amsterdam

Get involved at World Vaccine Congress Europe 2026

TO SPONSOR

Christian Larsmon Christian.Larsmon@terrapinn.com

Otto Squire Otto.Squire@terrapinn.com

TO SPEAK

Isla Sutherland Isla.Sutherland@terrapinn.com

MARKETING & PRESS

Jasper Cameron Jasper.Cameron@terrapinn.com

Stay Up-to-Date

Created by

R&D + Strategic Partnering For The
Global Vaccine Industry

Join the global vaccine community in Amsterdam
19-22 October, Amsterdam

Christian Larsmon
Christian.Larsmon@terrapinn.com

Otto Squire
Otto.Squire@terrapinn.com

Isla Sutherland
Isla.Sutherland@terrapinn.com

Jasper Cameron
Jasper.Cameron@terrapinn.com